<DOC>
	<DOCNO>NCT01596842</DOCNO>
	<brief_summary>Extra-renal source 1 , 25-dihydroxyvitamin D increase normal serum 1 , 25-dihydroxyvitamin D level chronic kidney disease patient administration high dose 25-hydroxyvitamin D. The investigator observe 1 , 25-dihydroxyvitamin D concentration significantly increase 3 month omega-3 FA supplementation compare baseline level without 25-hydroxyvitamin D administration dialysis patient . In study , investigator hypothesize omega-3 FA 25-hydroxyvitamin D supplementation may increase 1 , 25-dihydroxyvitamin D concentration much compare 25-hydroxyvitamin D supplementation hemodialysis patient insufficient deficient 25-hydroxyvitamin D level .</brief_summary>
	<brief_title>Effect Omega-3 Fatty Acid Vitamin D Activation</brief_title>
	<detailed_description />
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Patients treat hemodialysis least 6 month 25hydroxyvitamin D &lt; 30 ng/mL Patients history active infection within 3 month , Patients fish oil omega3 fatty acid supplementation within 3 month , Patients history fish , gelatin , and/or omega3 fatty acid allergy , Patients history hospital admission within 3 month , Patients history bleed within 3 month , Patients thrombocytopenia , Patients current use warfarin , Patients albumin level &lt; 3.0 g/dL , Patients malignancy and/or liver cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Omega-3 fatty acid</keyword>
	<keyword>vitamin D</keyword>
	<keyword>ergocalciferol</keyword>
	<keyword>hemodialysis</keyword>
</DOC>